Treatment of myoclonic syndromes with paroxetine alone or combined with 5-HTP.
D006916:5-Hydroxytryptophan / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D017374:Paroxetine; D010880:Piperidines / Q000627:therapeutic use*; D012701:Serotonin / Q000134:cerebrospinal fluid; D012702:Serotonin Antagonists; D013577:Syndrome
D010880:Piperidines; D012702:Serotonin Antagonists; D012701:Serotonin; D017374:Paroxetine; D006916:5-Hydroxytryptophan